AAAAAA

   
Results: 1-14 |
Results: 14
Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate
Authors: Markowitz, GS Appel, GB Fine, PL Fenves, AZ Loon, NR Jagannath, S Kuhn, JA Dratch, AD D'Agati, VD
Citation: Gs. Markowitz et al., Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate, J AM S NEPH, 12(6), 2001, pp. 1164-1172
Therapeutic dilemmas with thalidomide in multiple myeloma: Case discussions
Authors: Desikan, RK Jagannath, S
Citation: Rk. Desikan et S. Jagannath, Therapeutic dilemmas with thalidomide in multiple myeloma: Case discussions, SEMIN ONCOL, 28(6), 2001, pp. 593-596
Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone
Authors: Desikan, KR Tricot, G Munshi, NC Anaissie, E Spoon, D Fassas, A Toor, A Zangari, M Badros, A Morris, C Vesole, DH Siegel, D Jagannath, S Barlogie, B
Citation: Kr. Desikan et al., Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone, BR J HAEM, 112(1), 2001, pp. 242-247
Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone
Authors: Desikan, KR Tricot, G Dhodapkar, M Fassas, A Siegel, D Vesole, DH Jagannath, S Singhal, S Mehta, J Spoon, D Anaissie, E Barlogie, B Munshi, N
Citation: Kr. Desikan et al., Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone, BONE MAR TR, 25(5), 2000, pp. 483-487
Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cells
Authors: Li, YW Bendandi, M Deng, YP Dunbar, C Munshi, N Jagannath, S Kwak, LW Lyerly, HK
Citation: Yw. Li et al., Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cells, BLOOD, 96(8), 2000, pp. 2728-2733
Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cells
Authors: Li, YW Bendandi, M Dong, YP Dunbar, C Munshi, N Jagannath, S Kwak, LW Lyerly, HK
Citation: Yw. Li et al., Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cells, BLOOD, 96(8), 2000, pp. 2828-2833
Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities
Authors: Desikan, R Barlogie, D Sawyer, J Ayers, D Tricot, G Badros, A Zangari, M Munshi, NC Anaissle, E Spoon, D Siegel, D Jagannath, S Vesole, D Epstein, J Shaughnessy, J Fassas, A Lim, S Roberson, P Crowley, J
Citation: R. Desikan et al., Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities, BLOOD, 95(12), 2000, pp. 4008-4010
Rapid-onset subfulminant liver failure associated with troglitazone
Authors: Jagannath, S Rai, R
Citation: S. Jagannath et R. Rai, Rapid-onset subfulminant liver failure associated with troglitazone, ANN INT MED, 132(8), 2000, pp. 677-677
Stem cell transplantation for multiple myeloma - 10 years later
Authors: Siegel, DS Lim, SH Tricot, G Desikan, KR Fassas, A Mehta, J Singhal, S Anaissie, E Jagannath, S Barlogie, B
Citation: Ds. Siegel et al., Stem cell transplantation for multiple myeloma - 10 years later, HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 499-516
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma
Authors: Gale, RP Park, RE Dubois, RW Anderson, KC Audeh, WM Bergsagel, D Jagannath, S Kyle, RA Oken, MM Perlman, M Rifkin, RM Stone, MJ Durie, B
Citation: Rp. Gale et al., Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow autotransplants in newly diagnosed multiple myeloma, LEUK LYMPH, 33(5-6), 1999, pp. 511-517
Lymphomatoid granulomatosis following autologous stem cell transplantation
Authors: Fassas, A Jagannath, S Desikan, KR Shah, HR Shaver, R Waldron, J Munshi, NC Barlogie, B Tricot, G
Citation: A. Fassas et al., Lymphomatoid granulomatosis following autologous stem cell transplantation, BONE MAR TR, 23(1), 1999, pp. 79-81
High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia
Authors: Desikan, R Dhodapkar, M Siegel, D Fassas, A Singh, J Singhal, S Mehta, J Vesole, D Tricot, G Jagannath, S Anaissie, E Barlogie, B Munshi, NC
Citation: R. Desikan et al., High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia, BR J HAEM, 105(4), 1999, pp. 993-996
Total therapy with tandem transplants for newly diagnosed multiple myeloma
Authors: Barlogie, B Jagannath, S Desikan, KR Mattox, S Vesole, D Siegel, D Tricot, G Munshi, N Fassas, A Singhal, S Mehta, J Anaissie, E Dhodapkar, D Naucke, S Cromer, J Sawyer, J Epstein, J Spoon, D Ayers, D Cheson, B Crowley, J
Citation: B. Barlogie et al., Total therapy with tandem transplants for newly diagnosed multiple myeloma, BLOOD, 93(1), 1999, pp. 55-65
Biologic and therapeutic determinants of bone mineral density in multiple myeloma
Authors: Dhodapkar, MV Weinstein, R Tricot, G Jagannath, S Parfitt, AM Manolagas, SC Barlogie, B
Citation: Mv. Dhodapkar et al., Biologic and therapeutic determinants of bone mineral density in multiple myeloma, LEUK LYMPH, 32(1-2), 1998, pp. 121-127
Risultati: 1-14 |